3D-Printed GelMA/PEGDA/F127DA Scaffolds for Bone Regeneration

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Tissue-engineered scaffolds are crucial for bone defect treatment, requiring optimal structure and function for regeneration.
• Digital light processing (DLP) printing offers high resolution and gentle processing for bone tissue engineering (BTE).
• Common bioinks like PEGDA and F127DA have good printability but limited cell/tissue adhesion.

Purpose of the Study:

• To develop a novel compound BTE scaffold using DLP printing technology.
• To evaluate the efficacy of the new scaffold in promoting cell adhesion, proliferation, and osteogenic differentiation.
• To assess the in vivo bone regeneration capacity of the developed scaffold.

Main Methods:

• Fabrication of a GelMA/PEGDA/F127DA (GPF) scaffold using DLP printing technology.
• In vitro assessment of cell adhesion, proliferation, and osteogenic differentiation of mesenchymal stem cells.
• In vivo evaluation of bone regeneration by comparing GPF scaffolds with PEGDA/F127DA (PF) scaffolds and a blank group using micro-CT analysis.

Main Results:

• The GPF scaffold demonstrated enhanced cell adhesion and proliferation.
• The scaffold effectively promoted osteogenic differentiation of mesenchymal stem cells in an osteoinductive environment.
• In vivo, the GPF scaffold showed a significantly higher bone tissue volume/total tissue volume (BV/TV) (49.75 ± 8.50%) compared to the PF scaffold (37.10 ± 7.27%) and the blank group (20.43 ± 2.08%).

Conclusions:

• The developed GelMA/PEGDA/F127DA scaffold is a promising biomaterial for bone tissue engineering applications.
• DLP printing technology enables the fabrication of advanced scaffolds for enhanced bone regeneration.
• This novel scaffold offers a new therapeutic approach for the effective treatment of bone defects.